KA
KaroPharma Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Per Håkan Albin Åström, was filed 21 Dec 2017.
KaroPharma: what insiders have been doing
Insider filings for KaroPharma are scarce in the Finansinspektionen feed, the latest one published on 21 December 2017. This page will fill in as new trades are disclosed. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Insider Decl.
1
Thresholds
n/a
Buy Volume
€238,079
1 ops. · all time
Sell Volume
n/a
n/a
Financial data
· cache
Last declaration on 21 December 2017
Declarations1 total
- 82,203 shares@ SEK 29.00100.0% of flowFI:csv-5db6260674b09f1c29bcCanonical exit: 12 Mar 2018 (T+90)
1 of 1 declaration
About KaroPharma
KaroPharma is a Swedish pharmaceutical company focused on the development and commercialization of pharmaceutical products. It is listed on the Stockholm Stock Exchange.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations